CAPSONI, Simona
 Distribuzione geografica
Continente #
NA - Nord America 5.970
EU - Europa 1.147
AS - Asia 669
AF - Africa 7
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.796
Nazione #
US - Stati Uniti d'America 5.968
CN - Cina 387
TR - Turchia 255
UA - Ucraina 243
IT - Italia 218
DE - Germania 175
PL - Polonia 158
GB - Regno Unito 124
SE - Svezia 122
FI - Finlandia 81
VN - Vietnam 11
FR - Francia 9
SD - Sudan 6
BE - Belgio 5
HK - Hong Kong 4
IN - India 4
CZ - Repubblica Ceca 3
NL - Olanda 3
AU - Australia 2
CA - Canada 2
JP - Giappone 2
BG - Bulgaria 1
CH - Svizzera 1
DK - Danimarca 1
ES - Italia 1
EU - Europa 1
IL - Israele 1
IR - Iran 1
KR - Corea 1
LT - Lituania 1
RO - Romania 1
SA - Arabia Saudita 1
SG - Singapore 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 7.796
Città #
Fairfield 899
Woodbridge 794
Houston 593
Ann Arbor 434
Chandler 418
Jacksonville 403
Ashburn 385
Seattle 348
Cambridge 301
Wilmington 290
Izmir 171
Warsaw 158
Nanjing 108
Milan 98
Princeton 98
Boardman 75
San Diego 69
Beijing 67
Dearborn 45
Ferrara 42
Addison 41
Nanchang 41
Falls Church 38
Boydton 31
Shenyang 27
Hebei 26
Des Moines 23
Jiaxing 21
Mountain View 21
Redwood City 17
Changsha 15
Shanghai 15
Tianjin 14
Norwalk 13
Dong Ket 11
Kunming 11
London 9
New York 9
Lanzhou 8
Tappahannock 8
Jinan 7
Orange 7
Changchun 5
Rome 5
Auburn Hills 4
Brussels 4
Filago 4
Indiana 4
Kilburn 4
Los Angeles 4
San Francisco 4
Walnut 4
Detroit 3
Florence 3
Guangzhou 3
Khartoum 3
Mezzolombardo 3
Perugia 3
Stockholm 3
Washington 3
Zhengzhou 3
Ansbach 2
Chengdu 2
Chicago 2
Chiswick 2
Hefei 2
Helsinki 2
Hong Kong 2
Lawrence 2
New Bedfont 2
Paris 2
Philadelphia 2
Phoenix 2
Prescot 2
Pune 2
Redmond 2
Shaoxing 2
Simi Valley 2
Toronto 2
Birmingham 1
Bologna 1
Capri 1
Caserta 1
Central 1
Centurion 1
Coeur d'Alene 1
Council Bluffs 1
Den Haag 1
Dortmund 1
East Lansing 1
Ferrara di Monte Baldo 1
Fuzhou 1
Gent 1
Haifa 1
Haikou 1
Hangzhou 1
Hanover 1
Hounslow 1
Imola 1
Kish 1
Totale 6.335
Nome #
Phenotypic knockout of nerve growth factor in adult transgenic mice reveals severe deficits in basal forebrain cholinergic neurons, cell death in the spleen and skeletal muscle dystrophy 245
NGF steers microglia toward a neuroprotective phenotype 228
The chemokine CXCL12 mediates the anti-amyloidogenic action of painless human nerve growth factor 126
Amyloid plaque-independent deficit of early postnatal visual cortical plasticity in the 5xFAD transgenic model of Alzheimer's disease. 125
Characterization of melatonin receptors and signal transduction system in rat arteries forming the circle of Willis 117
Delivery of NGF to the brain: intranasal versus ocular administration in anti-NGF transgenic mice 114
On the molecular basis linking Nerve Growth Factor (NGF) to Alzheimer’s disease 113
Acute cholinergic rescue of synaptic plasticity in the neurodegenerating cortex of anti-nerve-growth-factor mice 110
Neutralization of Nerve Growth Factor impairs proliferation and differentiation of adult neural progenitors in the subventricular zone 110
Nerve growth factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice 109
Alzheimer-like neurodegeneration in aged antinerve Growth factor transgenic mice 109
Intranasal "painless" human nerve growth factors slows amyloid neurodegeneration and prevents memory deficits in app x PS1 mice 108
Environmental enrichment delays the onset of memory deficits and reduces neuropathological hallmarks in a mouse model of Alzheimer-like neurodegeneration 107
A dual mechanism linking NGF/ProNGF imbalance and early inflammation to Alzheimer's disease neurodegeneration in the AD11 anti-NGF mouse model 106
Functional Characterization of Human ProNGF and NGF Mutants: Identification of NGF P61SR100E as a "Painless" Lead Investigational Candidate for Therapeutic Applications 105
Dark rearing blocks the developmental down-regulation of brain-derived neurotrophic factor messenger RNA expression in layers IV and V of the rat visual cortex 104
Identification of a caspase-derived N-terminal tau fragment in cellular and animal Alzheimer's disease models 103
Pathogen-Free Husbandry Conditions Alleviate Behavioral Deficits and Neurodegeneration in AD10 Anti-NGF Mice. 102
Autoradiographic localization of putative melatonin receptors in the brains of two old world primates: Cercopithecus aethiops and Papio ursinus 102
A small molecule targeting the multifactorial nature of Alzheimer's disease 102
Dissecting the role of sortilin receptor signaling in neurodegeneration induced by NGF deprivation 100
null 100
ProNGF drives localized and cell selective parvalbumin interneuron and perineuronal net depletion in the dentate gyrus of transgenic mice 100
Gene expression biomarkers in the brain of a mouse model for Alzheimer's disease: Mining of microarray data by logic classification and feature selection 99
Taking pain out of NGF: a "painless" NGF mutant, linked to hereditary sensory autonomic neuropathy type V, with full neurotrophic activity 99
The positional identity of mouse ES cell-generated neurons is affected by BMP signaling 98
Early inflammation and immune response mRNAs in the brain of AD11 anti-NGF mice 97
Differential regulation of brain-derived neurotrophic factor messenger RNA cellular expression in the adult rat visual cortex 96
In vitro receptor binding properties of a "painless" NGF mutein, linked to hereditary sensory autonomic neuropathy type V 96
A carnivore species (Canis familiaris) expresses circadian melatonin rhythm in the peripheral blood and melatonin receptors in the brain 95
Rat visual cortical neurones express TrkA NGF receptor 95
Postnatal development of GFAP in mouse visual cortex is not affected by light deprivation 95
ProNGF\NGF imbalance triggers learning and memory deficits, neurodegeneration and spontaneous epileptic-like discharges in transgenic mice 95
Time window in cholinomimetic ability to rescue long-term potentiation in neurodegenerating anti-nerve growth factor mice 95
Melatonin signal transduction and mechanism of action in the Central Nervous System. Using the rabbit cortex as a model 94
Localization and characterization of melatonin binding sites in the brain of the rabbit (Oryctolagus cuniculus) by autoradiography and in vitro ligand-receptor binding 94
Development of a non invasive NGF-based therapy for Alzheimer's disease 93
Dissecting the involvement of tropomyosin-related kinase A and p75 neurotrophin receptor signaling in NGF deficit-induced neurodegeneration 93
Transgenic mice with chronic NGF deprivation and Alzheimer's disease-like pathology display hippocampal region-specific impairments in short- and long-term plasticities 93
Peripheral Neutralization of Nerve Growth Factor Induces Immunosympathectomy and Central Neurodegeneration in Transgenic Mice 93
Intranasal delivery of therapeutic proteins for neurological diseases 92
Nerve growth factor regulates axial rotation during early stages of chick embryo development 92
SorLA Deficiency Dissects Amyloid Pathology from Tau and Cholinergic Neurodegeneration in a Mouse Model of Alzheimer's Disease 92
Functional blockade of tyrosine kinase A in the rat basal forebrain by a novel antagonistic anti-receptor monoclonal antibody 91
2-Bromomelatonin: synthesis and characterization of a potent melatonin agonist 91
Towards non invasive nerve growth factor therapies for Alzheimer's disease 91
Reduction of regional cerebral blood flow by melatonin in young rats 91
From genes to pain: nerve growth factor and hereditary sensory and autonomic neuropathy type V 91
Ganstigmine and donepezil improve neurodegeneration in AD11 antinerve growth factor transgenic mice 90
null 89
Non-human transgenic animals for the study of neurodegenerative syndromes 88
Mismatch between BDNF mRNA and protein expression in the developing visual cortex: the role of visual experience 86
Nerve growth factor scales endocannabinoid signaling by regulating monoacylglycerol lipase turnover in developing cholinergic neurons 86
Pathogen Free Conditions Slow the Onset of Neurodegeneration in a Mouse Model of Nerve Growth Factor Deprivation 86
Distribution and characterization of the melatonin receptors in the hypothalamus and pituitary gland of three domestic ungulates 84
Toxic properties of microsome-associated alpha-synuclein species in mouse primary neurons 84
Endogenous A beta causes cell death via early tau hyperphosphorylation 83
Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice 83
Muscular dystrophy in adult and aged anti-NGF transgenic mice resembles an inclusion body myopathy 80
In the adult hippocampus, chronic nerve growth factor deprivation shifts GABAergic signaling from the hyperpolarizing to the depolarizing direction 80
Painless Nerve Growth Factor: A TrkA biased agonist mediating a broad neuroprotection via its actions on microglia cells 80
Electrophysiological and behavioral effect of ozone on mice olfactory bulb 77
Long-term memantine treatment prevents behavioral deficits in a mouse model of sporadic Alzheimer's disease 76
The retina as a window to early dysfunctions of Alzheimer's disease following studies with a 5xFAD mouse model 76
Beta-amyloid plaques in a model for sporadic Alzheimer's disease based on transgenic anti-nerve growth factor antibodies 74
Effects of the cholinesterase inhibitor galantamine in a mouse model of Alzheimer's disease, the anti-nerve growth factor AD11 transgenic mice 74
Failure of nicotine-dependent enhancement of synaptic efficacy at Schaffer-collateral CA1 synapses of AD11 anti-nerve growth factor transgenic mice 73
Rescue of the neurodegenerative phenotype in AD11 anti-NGF mice. 71
Cholinergic striatal neurons are increased in HSAN V homozygous mice despite reduced NGF bioavailability 65
Non-human transgenic animals for the study of neurodegenerative syndromes 64
Memoquin: A new therapeutic poly-agent for Alzheimer's disease 63
Abeta-dependent Inhibition of LTP in different intracortical circuits of the visual cortex: the role of RAGE 61
Interaction between NH2-tau fragment and Aß in AD mitochondria contributes to the synaptic deterioration 61
Receptor for advanced glycation end product-dependent activation of p38 mitogen-activated protein kinase contributes to amyloid-beta-mediated cortical synaptic dysfunction 61
Antagonization of NGF in adult mice by transgenic antibodies causes progressive learning and memory impairments 59
Nerve Growth Factor regulates astrocyte physiology in vivo 59
Distribution and pharmacological characterization of melatonin receptors in the brain of the Japanese quail (Coturnix japonica) 54
null 54
Vasoactive intestinal peptide-like immunoreactive fibers in the pineal gland of the sheep 51
Characterization of endothelinA receptors in cerebral and peripheral arteries of the rat 51
Expression of the melatonin receptor in Xenopus laevis: A comparative study between protein and mRNA distribution 50
INIBITORE DI TNF ALPHA ASTROCITARIO PER L’USO NEL TRATTAMENTO DI MALATTIE NEUROLOGICHE 49
Muteins of hNGF, therapeutic uses and pharmaceutical compositions 48
The NGFR100W Mutation Specifically Impairs Nociception without Affecting Cognitive Performance in a Mouse Model of Hereditary Sensory and Autonomic Neuropathy Type V 45
null 41
Inhibitor of astrocyte TNF alpha for use in the treatment of neurological diseases 39
null 35
Intranasal delivery of BDNF rescues memory deficits in AD11 mice and reduces brain microgliosis 30
Involvement of Bradykinin Receptor 2 in Nerve Growth Factor Neuroprotective Activity 30
Nerve Growth Factor Neutralization Promotes Oligodendrogenesis by Increasing miR-219a-5p Levels 25
Graphene Promotes Axon Elongation through Local Stall of Nerve Growth Factor Signaling Endosomes 25
Acute cholinergic rescue of synaptic plasticity in the neurodegenerating cortex of anti-nerve growth factor mice 21
Alzheimer-like neurodegeneration in aged anti-nerve growth factor mice 20
Unraveling the Role of Dopaminergic and Calretinin Interneurons in the Olfactory Bulb 16
Temporal progression of ALzheimer-like neurodegeneration in mice expressing anti-Nerve Growth Factor recombinant antibodies 16
Enteric Alpha-Synuclein Inclusions, Colonic Inflammation, Increased Mucosal Permeability and Alterations of Bowel Neuromuscular Functions Precede Central Neurodegeneration in a Transgenic Mouse Model of Parkinson's Disease 16
Characterization by Gene Expression Analysis of Two Groups of Dopaminergic Cells Isolated from the Mouse Olfactory Bulb 16
Taking pain out of NGF: a "painless" NGF mutant with full neurotrophic activity 15
Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson’s disease before brain pathology 12
Getting Into the Brain: The Intranasal Approach to Enhance the Delivery of Nerve Growth Factor and Its Painless Derivative in Alzheimer’s Disease and Down Syndrome 12
Totale 7.980
Categoria #
all - tutte 28.867
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.867


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019973 0 0 0 0 0 0 0 0 0 223 302 448
2019/20201.998 331 79 122 335 183 236 207 167 175 75 51 37
2020/20211.227 107 74 48 145 61 113 29 147 51 200 161 91
2021/2022954 48 119 84 33 39 40 61 62 31 81 84 272
2022/20231.036 141 60 12 134 158 124 121 86 123 9 50 18
2023/2024273 53 66 19 20 24 41 10 31 3 6 0 0
Totale 8.007